Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-05-21 @ 12:08 PM
Study NCT ID:
NCT02908269
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2016-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Influenza | View |